drugset
drugset / Trial / NCT03261960

A Safety and Efficacy Comparison of BLI4700 Bowel Preparation Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy

NCT03261960 ↗

Phase 3 Completed 389 enrolled Braintree Laboratories
RandomizedParallel-groupSingle-blindTreatment

Summary

The objective of this study is to compare the safety and efficacy of BLI4700 bowel preparation to an FDA-approved bowel preparation as 2-day, split-dose bowel preparations prior to colonoscopy in adult patients.

Timeline

Start
2017-08-08
Primary completion
2018-03-26
Completion
2018-03-26

Drugs

EvaluationDrugModalityDoseRoute
Subject BLI4700 Unknown — Oral

Indications

No indication recorded.